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Whether genetic and familial factors inf luence the association between cardiorespiratory fitness (CRF) and
cardiovascular disease (CVD) is unknown. Two cohorts were formed based on data from 1,212,295 men aged
18 years who were conscripted for military service in Sweden during 1972–1996. The first comprised 4,260 twin
pairs in which the twins in each pair had different CRF (≥1 watt). The second comprised 90,331 nonsibling pairs
with different CRF and matched on birth year and year of conscription. Incident CVD and all-cause mortality
were identified using national registers. During follow-up (median 32 years), there was no difference in CVD and
mortality between fitter twins and less fit twins (246 vs. 251 events; hazard ratio (HR) = 1.00, 95% confidence
interval (CI): 0.83, 1.20). The risks were similar in twin pairs with ≥60-watt difference in CRF (HR = 0.96, 95% CI:
0.57, 1.64). In contrast, in the nonsibling cohort, fitter men had a lower risk of the outcomes than less fit men (4,444
vs. 5,298 events; HR = 0.83, 95% CI: 0.79, 0.86). The association was stronger in pairs with ≥60-watt difference
in CRF (HR = 0.65, 95% CI: 0.59, 0.71). These findings indicate that genetic and familial factors inf luence the
association of CRF with CVD and mortality.
aerobic fitness; cardiovascular disease; physical activity; twin study
Abbreviations: CI, confidence interval; CRF, cardiorespiratory fitness; CVD, cardiovascular disease; HR, hazard ratio; ICD,
International Classification of Diseases; MI, myocardial infarction; PA, physical activity; SD, standard deviation.
Today, it is widely accepted that being physically active
and fit is fundamental to one’s overall health. This notion is
also supported by a compelling body of evidence showing
that physical activity (PA) and cardiorespiratory fitness
(CRF) are inversely associated with a wide spectrum of ad-
verse health outcomes including cardiovascular disease
(CVD), type 2 diabetes mellitus, common types of cancer,
dementia, and mortality (1–7). In addition to having adverse
effects on individuals, a sedentary lifestyle and low CRF
place a substantial economic burden on society (8, 9). In con-
trast, high CRF has been associated with reduced health-care
expenses (10).
Despite all this knowledge, the prevalence of inactivity
and low CRF remains high (11, 12), and a decline in CRF
has been observed especially among young men during the
past 2 decades (13). In light of this finding, it is interesting
that the incidence of CVD decreased during the same time
period (14, 15). This is partly due to enhanced treatment and
primary and secondary prevention, such as improvements in
hypertension treatment and control, reductions in cholesterol
levels, and declines in smoking prevalence (16). Even so,
given the trends in CRF, the question of whether the associ-
ation of CRF with CVD is causal or whether it is influenced
by other factors remains.
Early research suggested that hereditary factors substan-
tially influence CRF (17). Since then, maternal heritage
specifically has been shown to significantly influence CRF
(18, 19), and large twin studies show that at least 65% to 78%
of the variance in CRF among young men is attributable to
genetic factors (20, 21). Interestingly, it is suggested that cer-
tain factors linked to CRF, such as peroxisome proliferator-
activated receptor α gene and vascular endothelial growth
factor gene expression, also play a role in atherosclerosis
(22–24). Thus, there are grounds to believe that genetic
and familial factors might influence the association between
CRF and incident CVD. One way to examine the influence






/aje/article/189/10/1114/5819839 by guest on 18 February 2021
CVD and Mortality in Twins With Discordant Fitness 1115
of genetic and familial factors is to compare twins with
discordant levels of CRF; a lower risk of adverse outcomes
in twins with higher CRF would suggest that the associa-
tion is attributable to behavioral factors, such as PA, rather
than genetic predisposition and familial resemblance. In the
present study, we therefore examined the association of
CRF in late adolescence with incident CVD and all-cause
mortality later in life in male twins with discordant levels
of CRF.
METHODS
Study design and cohorts
The present study was a retrospective cohort study ap-
proved by the Regional Ethical Review Board in Umeå,
Sweden (No. 2010–13-31M) and by the Swedish National
Board of Health and Welfare. It was based on register data
from 1.4 million Swedish men who participated in com-
pulsory national military conscription during 1972–1996.
Only 2%–3% of all Swedish men were relieved from con-
scription due to severe chronic conditions. In connection to
conscription, all conscripts took part in highly standardized
physical and mental tests for 2 days. A medical doctor
examined the participants, using the International Classi-
fication of Diseases (ICD), Eighth Revision, and all con-
scripts underwent a resting electrocardiogram to evaluate
heart function. To be considered for inclusion in this study,
participants had to have partaken in a bicycle-ergometer
test assessing their CRF in connection with conscription
and obtained a test result of ≥100 watts. From these par-
ticipants (n = 1,212,295), 2 study cohorts were created.
The primary study cohort included twins, defined as full
siblings born within 1 week of each other, with discordant
CRF (difference of ≥1 watt). The twins were identified by
linking the conscription registry data with family data from
Statistics Sweden. Initially, 6,113 twin pairs were identified,
of which 4,260 pairs had undergone CRF testing and had
discordant CRF. Thus, the primary study cohort comprised a
total of 8,520 men. The second study cohort was a nonsibling
cohort selected from the same population. The purpose of
this cohort was to form pairs that would have twin-like
characteristics without the actual genetic component. Thus,
nonsiblings with discordant CRF (difference of ≥1 watt)
were matched 1:1 on birth year, year of conscription, body
height (within 3 cm), and body weight (within 5 kg). This
nonsibling cohort comprised 90,331 matched pairs, resulting
in a total cohort of 180,662 men.
Exposure measurement
CRF was assessed using a validated and reliable elec-
trically braked bicycle-ergometer test, previously described
(25). Prior to testing, participants were required to present
normal findings from a resting electrocardiogram before
being given permission to perform the bicycle test. The test
began with a 5-minute submaximal warmup where the resis-
tance was set at a point from 75 to 150 watts depending on
the participant’s body weight. During the test, participants
were instructed to pedal at a cadence of 60–70 revolutions
per minute. When the warmup was completed, the workload
was progressively increased by 25 watts/minute. The test
was finished when the participant fatigued and was unable
to continue pedaling at the prespecified cadence. The final
work rate in watts was then recorded as the participant’s
level of CRF, which served as the primary exposure in the
subsequent analysis. Given that a higher body weight con-
tributes to higher absolute watts, which could lead to over-
estimation of CRF among heavier people, an additional
exposure in terms of weight-adjusted CRF (watts/kg) was
used. This was calculated by dividing the absolute watts by
body weight for each participant.
CVD and mortality ascertainment
Participants were followed until the first of the following:
an initial diagnosis of CVD (myocardial infarction (MI),
stroke, or angina pectoris), death, or December 31, 2016.
The primary study outcome was the composite endpoint
of CVD and all-cause mortality. As secondary outcomes,
CVD and all-cause mortality were analyzed separately. Data
on mortality were retrieved from the Swedish Cause of
Death Registry. All cases of incident CVD were tracked
through the Swedish National Inpatient Register. ICD codes
from the Ninth and Tenth Revisions were used to identify
diagnoses of MI (ICD-9: 410; ICD-10: I61), stroke (ICD-
9: 431–434; ICD-10: I61-I64), and angina pectoris (ICD-
9: 413; ICD-10: I20). The Inpatient Register is managed
by the Swedish National Board of Health and Welfare and
contains information on approximately 90% of all inpatient
care in Sweden since 1971 and 100% since 1987. Diagnoses
recorded in the Inpatient Register have been shown to have
a positive predictive value of 85%–95% in general (86%–
100% for MI, 69%–99% for stroke, 95% for angina pectoris)
(26–28).
Confounding and additional variable measurements
Body weight was measured using a standardized scale
and height was measured using a wall-mounted gauge. The
body mass index was calculated by dividing body weight by
height squared. Blood pressure was measured using a mer-
cury sphygmomanometer with the participant in a supine
position. Data on smoking and cardiometabolic blood mark-
ers were not available. As previously described (29), smok-
ing status among conscripts was registered only in a small
subcohort during 1969–1978, from which nearly all data
were obtained during 1969–1970, and thus not eligible for
inclusion in the present study. Socioeconomic data, includ-
ing disposable annual household income, relationship status,
and level of education, were retrieved from the Longitudinal
Integration Database for Health Insurance and Labor Market
Studies, initiated in 1990. To maximize sufficient avail-
ability of socioeconomic data for conscripts, we retrieved
socioeconomic data from 2000 for all participants. Data on
disposable annual household income was missing for 167
participants in the twin cohort and 4,544 participants in the
nonsibling cohort. All the registers used in the present study
were linked using personal identification numbers, which all
Swedish residents have.
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Statistical analysis
Baseline differences between more and less fit individuals
were tested using independent-samples t tests for continuous
variables and Pearson’s χ2 tests for categorical variables.
To compare more and less fit individuals with respect to
the study outcomes, hazard ratios and confidence intervals
were estimated using conditional Cox regression models that
were stratified by matched pairs. The proportional hazards
assumption was not violated according to an analysis of
Schoenfeld residuals. In the main analysis, CRF discor-
dance was analyzed as a categorical variable (0, 1), and
the models were adjusted for confounders in 2 steps. First,
adjustments were made for socioeconomic factors includ-
ing annual household disposable income, relationship status
(unmarried, married, divorced, registered partner), and level
of education (≤9 years of elementary school, ≤2 years of
high school, ≥3 years of high school, <3 years of university,
≥3 years of university, doctoral studies). Next, the models
additionally adjusted for body mass index, systolic blood
pressure, and diastolic blood pressure. The models did not
adjust for age at baseline or year of conscription because
the subjects were matched on these variables. Given that
the ≥1-watt within-pair difference in CRF might have been
insufficient to detect differences in risks, the associations
of CRF with the composite endpoint was investigated in
subgroups defined by larger within-pair discordances in
CRF. Previous research has shown that that an increase in
CRF equivalent to 17.5 watts is associated with 13%–15%
lower risk of CVD and mortality (30). Hence, we performed
subgroup analyses where the within-pair difference in CRF
was ≥10 watts, ≥20 watts, ≥30 watts, ≥40 watts, ≥50 watts,
and ≥60 watts. Further analyses based on even larger within-
pair differences were not performed because there was an
insufficient number of events for adequate statistical power.
In a secondary analysis, CRF was placed into a con-
ditional Cox model as a continuous variable to estimate
the increase in risk per 10-watt increment in within-pair
difference in CRF. Adjustments were made according to the
same procedure as in the main analysis.
In the twin cohort, a sensitivity analysis was performed to
evaluate whether CRF was associated with CVD and mor-
tality when not accounting for genetic and familial factors.
In this analysis, one twin in each pair was excluded, and the
associations were evaluated per standard-deviation increase
in CRF using unconditional Cox regression. These analyses
were adjusted in the same way as the main analysis. All
analyses were performed using SPSS, version 25.0 (IBM
Corp., Armonk, New York), and Stata, version 15 (StataCorp
LLC, College Station, Texas). Statistical significance was
determined based on confidence intervals for the hazard
ratios, where confidence intervals that did not overlap 1.0
were considered statistically significant.
RESULTS
Baseline characteristics
In the twin cohort (Table 1), the mean age at baseline was
18.3 years (standard deviation (SD), 0.6 years). The median
difference in CRF between twins was 25 watts (interquartile
range, 12–47), with a mean difference of 33 watts. There
were small differences in anthropometrics and systolic blood
pressure between more and less fit twins. In the matched
nonsibling cohort (Table 1), the mean age at baseline was
18.3 (0.7) years. The median difference in CRF between
nonsiblings was 36 watts (interquartile range, 18–62), with
a mean difference of 44 watts. There were small differences
in age, anthropometrics, blood pressure, and socioeconomic
variables between more and less fit men.
CVD and mortality in twins
During a median follow-up time of 32.3 years (interquar-
tile range, 27.0–37.6), a total of 497 outcome events (angina,
93; MI, 94; stroke, 70; death, 294) occurred in the twin
cohort (Figure 1). The incidence rate of the composite
endpoint of CVD and mortality was 17.8/10,000 person-
years in fitter twins compared with 18.2 per 10,000 person-
years in less fit twins. As shown in Table 2, fitter twins
did not have a lower risk of CVD and mortality before
adjustment for confounders (hazard ratio (HR) = 1.00, 95%
confidence interval (CI): 0.83, 1.20) or after adjustment
(HR = 0.90, 95% CI: 0.72, 1.12). The association was
weaker in twin pairs discordant for CRF/body weight
(HR = 0.99, 95% CI: 0.80, 1.24) (Table 3). When analyzed
as a continuous variable, each 10-watt increment in within-
pair difference in CRF was not associated with CVD
and mortality either before adjustment for confounders
(HR = 1.01, 95% CI: 0.97, 1.06) or after (HR = 1.00, 95% CI:
0.94, 1.05).
Subgroup analyses showed that CRF was not associated
with CVD and mortality in twin pairs with a difference in
CRF of at least 10 watts (HR = 0.94, 95% CI: 0.76, 1.15) or
in twin pairs with a difference in CRF of at least 60 watts
(HR = 0.96, 95% CI: 0.57, 1.64) (Figure 2).
CVD and mortality in nonsiblings
In the matched nonsibling cohort, 9,742 outcome events
(angina, 1,980; MI, 2,322; stroke, 1,658; death, 6,194)
occurred during a median follow-up time of 32.3 years
(interquartile range, 27.1–38.3) (Figure 3). The incidence
rate of CVD and mortality was 15.0/10,000 person-years
in fitter men compared with 18.0/10,000 person-years in
less fit men. As shown in Table 2, fitter men had a lower
risk of CVD and mortality, both before adjustment for
confounders (HR = 0.83, 95% CI: 0.79, 0.86) and after
adjustment (HR = 0.87, 95% CI: 0.83, 0.92). Similar results
were observed for the secondary outcomes (Table 2), and
the associations remained in pairs discordant for CRF/body
weight (HR = 0.89, 95% CI: 0.84, 0.93) (Table 3). When
analyzed as a continuous variable, each 10-watt increment
in within-pair difference in CRF among nonsiblings was
associated with CVD and mortality after adjustment for
confounders (HR = 0.97, 95% CI: 0.96, 0.98).
Subgroup analyses showed that higher CRF was associ-
ated with lower risk of CVD and mortality in nonsibling
pairs with a difference in CRF of at least 10 watts (HR = 0.81,
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Figure 1. Cumulative incidence of cardiovascular disease and mor-
tality in the twin cohort among Swedish men who were 18 years of
age in 1972–1996. The hazard ratio for fitter twins compared with
less fit twins was 1.00 with a 95% confidence interval of 0.83, 1.20.
95% CI: 0.78, 0.85) up to at least 60 watts (HR = 0.65, 95%
CI: 0.59, 0.71) (Figure 2).
Sensitivity analyses
In the twin cohort, using unconditional Cox regression,
CRF was associated with lower risk of CVD and mortality
when excluding the less fit twin in each pair (HR for 1-SD
increase in CRF = 0.74, 95% CI: 0.64, 0.85) or when ex-
cluding the fitter twin in each pair (HR for 1-SD increase in
CRF = 0.83, 95% CI: 0.73, 0.96), before adjustment. Fully
adjusting models showed similar associations when exclud-
ing the less fit twin (HR for 1-SD increase in CRF = 0.75,
95% CI: 0.63, 0.89) or when excluding the fitter twin (HR
for 1-SD increase in CRF = 0.86, 95% CI: 0.73, 1.02).
In the twin cohort, a post-hoc power calculation was
performed under the assumptions of no matching, a cohort
size of 8,520, 497 outcomes, and a 2-sided 5% significance
level. The statistical power was estimated to be 21.6%,
44.1%, 70.1%, and 89.4% for expected hazard ratios of 0.90,
0.85, 0.80, and 0.75, respectively.
DISCUSSION
In this nationwide study, higher CRF was associated
with a lower risk of early CVD and mortality in matched
pairs of nonsiblings, which corroborates the results of
previous studies (4, 29, 31, 32). However, no association
was observed in twin pairs, and the results remained in twin
pairs with greater-than-average differences in CRF. These
findings were even more pronounced when analyzing CRF
relative to body weight. Together, these findings suggest that
genetic and familial factors exert a sizeable influence on the
association of CRF with the risk of early CVD and mortality
in young men.
The relationship between CRF and adverse events,
including CVD and mortality, has been subject to rigorous
investigation (3–7). Not long ago, the American Heart
Association highlighted emerging evidence suggesting that
low CRF might be as strong a predictor of mortality as, if
not stronger than, traditional risk factors such as smoking,
obesity, and cardiometabolic abnormalities (33). In a meta-
analysis, the pooled estimates of risk reduction of CVD and
all-cause mortality per increase in CRF equivalent to 17.5
watts for a 70-kg person were 13% and 15%, respectively
(30). However, there was a substantial heterogeneity in risk
estimates across the individual studies. In previous studies,
Högström et al. (29, 31) demonstrated that the risk of stroke
and MI was reduced by 16%–24% per 1-standard-deviation
increase in CRF among military conscripts, who constituted
the study population in the present study as well. Thus,
the mean difference of 33 watts between conscripted twins
in the present study is clinically relevant and should have
been associated with a similar risk reduction in CVD and
mortality if the association was independent of genetic and
familial factors. Yet, the fitter twins did not have a lower risk
of CVD and mortality compared with the less fit twins. We
then further explored the association of CRF with CVD and
mortality in twin pairs with increasing differences in CRF;
still, the absence of association persisted. While this could
partly be due to the relatively low number of events in the
subgroups, the results of these analyses, as well as the sensi-
tivity analysis, suggest that genetic and familial factors play
an important role in the association of CRF with CVD and
mortality. Given that behavioral factors likely explain the
difference in CRF within twin pairs, the results also suggest
that higher levels of lifestyle-acquired CRF, including gene-
behavior interactions, might not be effective in reducing the
risk of early CVD and mortality in young men.
To our knowledge, no previous study used a twin design
to explore the association between CRF and both CVD and
mortality. However, the association between self-reported
PA and mortality has previously been evaluated in twin
studies with somewhat inconclusive results. In studies based
on the Finnish Twin Cohort, lower risk of mortality was
observed in twins with higher levels of self-reported PA (34,
35). However, the associations were significant only in the
subcohort of dizygotic twins, which might indicate residual
genetic confounding or lack of statistical power. The latter
explanation is more likely; Carlsson et al. (36) observed
lower all-cause and cardiovascular mortality in a larger twin
cohort of monozygotic twins with discordant levels of self-
reported PA. Thus, together these results and the results of
the present study indicate that PA might influence the risk of
CVD and mortality through mechanisms other than a higher
CRF.
It would also be of interest to explore other behavioral
pathways that could influence the association between CRF
and the risk of disease and mortality. One possible mediating
factor is obesity. In a previous study, a co-twin design was
used to explore whether a higher body mass index would
contribute to a lower risk of MI, diabetes, and mortality
among 4,046 monozygotic twins (37). Interestingly, the
twins with lower body mass index did not have a lower risk
of MI or mortality, although they did have a lower risk of
diabetes. Overall, more studies are needed on the topic of
CRF in relation to the risk of disease and mortality.
Beyond the observational design, the present study has
some additional limitations that should be considered. First,
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Figure 2. Cardiovascular disease and mortality in twins and matched nonsiblings with increasing difference in cardiorespiratory fitness among
Swedish men who were 18 years of age in 1972–1996. CI, confidence interval; HR, (unadjusted) hazard ratio; IR, incidence rate (per 10,000
person-years); W, watts.
because CRF was measured only once in young adult-
hood, follow-up measurements later in life could have
led to different results. However, it should be noted
that higher CRF was associated with a lower risk of
the outcomes when genetic and familial factors were
not accounted for, as demonstrated by our nonsibling
analysis as well as by our sensitivity analysis, in which
one twin in each pair was excluded from the analy-
sis. Together, these findings are consistent with previ-
ous research in young men (29, 31, 32) and other age
groups (4, 30). In addition, while long-term studies on
changes in CRF throughout life are lacking, there was a
study with a 36-year follow-up that showed that physical
capacity in adolescence is a fairly stable predictor of
physical capacity in middle age (38). Second, the present
study cohort included only men, so no inferences can be
made for women. Third, the lack of associations in the
twin cohort could be due to a lack of statistical power.
As mentioned above, however, the mean difference of 33
watts between more and less fit twins was expected to
result in 16%–24% lower CVD and mortality, and a post-
hoc power analysis suggested that the statistical power to
detect such differences was sufficient. Fourth, the twin
cohort comprised both monozygotic and dizygotic twins.
In a previous evaluation of the conscription cohort, 46%
of twin pairs were found to be monozygotic (39), with a
substantial chance of residual genetic confounding. Yet, our
twin model appeared to adequately adjust for genetic and
familial factors given that the fitter twin did not have a lower
risk of CVD and mortality. Furthermore, the present study
lacked certain behavioral confounders, including smoking,
which is a major cause of CVD and mortality (40, 41).
However, because smoking is associated with lower CRF
(42), smoking status, and any residual genetic confounding,
would likely have further attenuated the regression esti-
mates. The primary strengths of this study include the unique
design with a large nationwide twin population, objectively
measured CRF, and a comprehensive set of analyses. These
strengths increase the internal and external validity of the
results.
In conclusion, the novel results of the present study sug-
gest that CRF is not associated with CVD and mortality
Figure 3. Cumulative incidence of cardiovascular disease and
mortality in the matched nonsibling cohort among Swedish men who
were 18 years of age in 1972–1996. The hazard ratio for fitter men
compared with less fit men was 0.83 with a 95% confidence interval
of 0.79, 0.86.
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when controlling for genetic and familial factors using a
male twin model. Given that the difference in CRF in the
twin cohort most likely is caused by behavioral factors, these
findings suggest that genetic and familial factors play an
important role in the association of CRF with CVD and
mortality and, by implication, that higher levels of lifestyle-
acquired CRF might not be effective in reducing the risk of
early CVD and mortality in men. Given the lack of previous
reports, it would be of value if these associations can be
confirmed in other twin cohorts, including cohorts of women
and older individuals.
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